Neurocrine Biosciences, Inc.
NBIX
$152.72
$1.901.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -60.05% | 39.50% | 37.57% | -9.22% | -6.09% |
| Total Receivables | 48.90% | 48.86% | 43.35% | 51.32% | 27.23% |
| Inventory | 83.13% | 9.14% | 20.21% | 51.31% | 33.88% |
| Prepaid Expenses | -- | -- | 251.96% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -67.36% | -47.61% | 82.08% | -43.96% | 0.42% |
| Total Current Assets | -6.37% | 48.73% | 46.27% | 15.02% | 4.74% |
|
|
|||||
| Total Current Assets | -6.37% | 48.73% | 46.27% | 15.02% | 4.74% |
| Net Property, Plant & Equipment | -7.79% | -8.69% | -7.91% | 67.86% | 70.26% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5,883.87% | -- | -- | 3.48% | 11.04% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -61.09% | -11.60% | -29.37% | -23.75% | 16.99% |
| Total Assets | 37.77% | 33.04% | 24.55% | 20.67% | 17.69% |
|
|
|||||
| Total Accounts Payable | 35.76% | 9.09% | 5.01% | 25.29% | -2.43% |
| Total Accrued Expenses | 53.59% | 37.32% | 42.56% | 56.36% | 42.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.95% | 25.66% | -- | 47.41% | 43.22% |
| Total Finance Division Other Current Liabilities | 280.50% | 582.91% | 44.56% | 9.09% | 591.30% |
| Total Other Current Liabilities | 280.50% | 582.91% | 44.56% | 9.09% | 591.30% |
| Total Current Liabilities | 60.08% | 59.06% | 46.43% | 48.48% | 37.09% |
|
|
|||||
| Total Current Liabilities | 60.08% | 59.06% | 46.43% | 48.48% | 37.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.49% | -9.23% | -8.75% | 70.41% | 71.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 85.25% | 43.67% | 32.19% | 44.96% | 48.90% |
| Total Liabilities | 39.31% | 30.10% | 22.09% | 54.65% | 50.23% |
|
|
|||||
| Common Stock & APIC | 14.14% | 11.27% | 9.30% | 2.79% | 1.64% |
| Retained Earnings | 756.80% | 11,224.53% | 1,433.22% | 262.52% | 273.51% |
| Treasury Stock & Other | -59.20% | -95.56% | 125.86% | -8.97% | 400.00% |
| Total Common Equity | 37.09% | 34.38% | 25.62% | 10.47% | 7.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.09% | 34.38% | 25.62% | 10.47% | 7.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 37.09% | 34.38% | 25.62% | 10.47% | 7.38% |
|
|
|||||